Resonance Health tackles growing prevalence of fatty liver disease and is awarded the 2014 WA Innovator of the Year Overall Winner for HepaFat-Scan
HepaFat-Scan is Resonance Health’s most recent marketable product for the diagnosis and monitoring of liver disease and addresses the growing global prevalence of fatty liver disease. Tim receiving WA Innovator of the Year Award
“Resonance Health is a Perth based company providing unique diagnostic imaging solutions for patients in Australia and internationally, and we are extremely proud to win this award,” Chief Scientist Professor Tim St Pierre said.
HepaFat-Scan reports volumetric fraction of fat in the liver, a measure that can be directly compared to a volumetric biopsy fat fraction measurement, providing patients and doctors with a more accurate diagnostic tool as part of a structured intervention protocol or clinical research trial.”
The Innovator of the Year Program is an annual event run by the Western Australian Department of Commerce that fosters a culture of innovation in Western Australia and acknowledges the achievements of WA’s leading innovation enterprises.
To read the full ASX announcement please click here.